YCYuhui Chen

Yuhui Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuhui Chen has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Tao Gong

    Neurology Department, Beijing Hospital,National Center for Gerontology;National Clinical Research Center for Gerontology;The Key Laboratory of Geriatrics of NHC;Institute of Geriatric Medicine,Chinese Academy of Medical Sciences, Beijing, China

    4 shared publications
  • Jiawen Yin

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    3 shared publications
  • Lei Xu

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    2 shared publications
  • Li Wang

    Department of Neurology, The Affiliated Hospital of Northwest University, Xi’an No.3 Hospital, Xi’an, China

    2 shared publications
  • Qianwen Wang

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    2 shared publications
  • Alimu Wufuer

    Department of Neurology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Clinical and Electrophysiological Characteristics of Peripheral Neuropathy in Immune-Related Adverse Event of Immune Checkpoint Inhibitors: A Retrospective Study and Literature Review

    by Lei Zhang, Fengzhi Liu, Yuhui Chen, Jia Guo, Xiang Wang, Huiyan Yu

    Purpose: To summarize clinical and laboratory characteristics of peripheral neurological immune-related adverse event (irAEs-PN) patients, to improve understanding and provide reference for early diagnosis of irAEs-PN caused by immune checkpoint inhibitors. Methods: We screened 61 patients with irAEs in our center from September 2020 to June 2025. In addition, studies with detailed clinical data related to irAEs-PN were collected in PubMed database from January 2015 to June 2025. A total of 50 patients with irAEs-PN were included, including 8 cases from our center and 42 cases reported in literature. The patients' demographic information, clinical characteristics, electrophysiological examination, therapy and outcomes were retrospectively analyzed and summarized. Results: Among the eight patients in our center, the first symptom was paresthesia, occurring in two cases, and limb weakness, occurring in six cases. Electrophysiology identified two axonal neuropathies, three demyelinating, and three mixed axonal and demyelinating neuropathies. Among the 42 patients reported in literature, the first symptom was paresthesia, occurring in 39 cases, and limb weakness, occurring in 41 cases. Electromyography identified 13 axonal neuropathies, 25 demyelinating neuropathies, and 4 mixed axonal and demyelinating neuropathies. Conclusions: In most patients, irAEs-PN is characterized by demyelinating sensorimotor involvement of both the upper and lower limbs. In individuals receiving immune checkpoint inhibitors, prompt electromyography after the onset of neuropathic symptoms can aid in detecting neurological involvement and facilitate earlier treatment.

  • Open Access

    The Evolving Burden of Stroke and Its Risk Factor Spectrum among Adults aged over 20 years old in Asia: A Systematic Analysis of Data from the Global Burden of Disease Study, 2019–2023

    by Yuhui Chen, Fengzhi Liu, Yuchang Zhou, Lei Xu, Heran Xie, Qi Wang, Ping Zeng, Tao Gong, Maigeng Zhou

    Background: Stroke has become an escalating challenge to global public health. Over 60% of the global population resides in Asia, and the notably high burden of stroke in this region contributes substantially to the overall global health burden.Methods: We estimated number of DALYs, age-standardized rates (ASR) of DALYs and percentage change for overall stroke, ischemic stroke, intracerebral hemorrhage and subarachnoid hemorrhage, for 48 countries and territories in Asia from 1990 to 2023. We analyzed the ranking of stroke burden attributable to 11 risk factors, their changes in the risk factor spectrum, and the burden by age group and sex.Findings: In 2023, the number of DALYs from overall stroke increased to 106.10 million (95% uncertainty interval (UI): 82.50–133.36 million), while the ASR of DALYs decreased by 29.34%. An exception was subarachnoid hemorrhage in South Asia, which showed an increased ASR. High systolic blood pressure remained the leading risk factor for each stroke subtype and accounted for the highest ASR of DALY in all age and sex groups. High BMI showed the largest increase in overall stroke burden since 1990, rising by 53.8% (95% UI: 53.37–54.24%).Interpretation: Stroke DALYs across Asian countries continued to increase in 2023, while ASR of DALY declined for overall stroke and each subtype. High systolic blood pressure remained the most prominent risk factor across all age and sex subgroups. High BMI emerged as the fastest-growing risk factor, recording the most substantial increase in attributable burden among all risk factors.

  • Relationship between CXCR4 and GNG4 in the Brain and Chronic Stress-Induced Atherosclerosis

    by Qianwen Wang, Lingbing Meng, Ruofan Xu, Jiawen Yin, Deping Liu, Lei Xu, Wei Li, Li Wang, Tao Gong, Yuhui Chen

    Chronic stress (CS) is recognized as a contributing factor to the progression of atherosclerosis (AS), but the molecular mechanisms within the central nerv


  • Open Access

    RF-AE: Single-site Arterial Elasticity Estimation Using UWB Signals

    by Zhi Wang, Beihong Jin, Yuhui Chen, Fusang Zhang, Siheng Li, Junqi Ma, Tao Gong, Yu Fu

    Arterial elasticity is the capability of the arteries to dilate and constrict in response to fluctuations in blood pressure as the heart circulates blood throughout the body, serving as an important indicator for assessing arterial health. However, conventional medical detection methods are often complex, costly, and require direct contact between the user's skin and the device, making them impractical for regular monitoring. In this paper, we propose a contactless single-site arterial elasticity assessment approach using ultra-wideband (UWB) signals, where we estimate the brachial-ankle pulse wave velocity, a key indicator of arterial health, by analyzing the UWB signals reflected off the back of a subject sitting still. Specifically, we first propose preprocessing methods to reduce noise in the received UWB signals, and then design a deep generative adversarial network to generate pulse wave signals from these UWB signals. The generated signals are of high quality and fidelity, exhibiting characteristics of vasoconstriction and vasodilation. Further, we analyze the pulse wave and extract the features related to arterial elasticity from the generated pulse waves. Finally, we employ random forest regression to predict pulse transit time and a body-height based method to estimate the length of the pulse transit path, so as to achieve single-site arterial elasticity assessment. We build the corresponding system named RF-AE and conduct extensive experiments to evaluate its performance. The experimental results show that RF-AE can accurately predict the arterial elasticity of users.


  • Development and validation of outcome prediction model for reperfusion therapy in acute ischemic stroke using nomogram and machine learning

    by Qianwen Wang, Jiawen Yin, Lei Xu, Jun Lu, Juan Chen, Yuhui Chen, Alimu Wufuer, Tao Gong

    Objective To develop logistic regression nomogram and machine learning (ML)-based models to predict 3-month unfavorable functional outcome for acute ischemic stroke (AIS) patients undergoing reperfusion therapy. Methods Patients undergoing reperfusion therapy (intravenous thrombolysis and/or endovascular treatment) were prospectively recruited. Unfavorable outcome was defined as 3-month modified Rankin Scale (mRS) score 3–6. The independent risk factors associated with unfavorable outcome were obtained by regression analysis and included in the prediction model. The performance of nomogram was assessed by the area under the curve (AUC), calibration curve, and decision curve analysis (DCA). ML models were compared with nomogram using AUC; the generalizability of all models was ascertained in an external cohort. Results A total of 505 patients were enrolled, with 256 in the model construction, and 249 in the external validation. Five variables were identified as prognostic factors: baseline NIHSS, D-dimer level, random blood glucose (RBG), blood urea nitrogen (BUN), and systolic blood pressure (SBP) before reperfusion. The AUC values of nomogram were 0.865, 0.818, and 0.779 in the training set, test set, and external validation, respectively. The calibration curve and DCA indicated appreciable reliability and good net benefits. The best three ML models were extra trees (ET), CatBoost, and random forest (RF) models; all of them showed favorable discrimination in the training cohort, and confirmed in the test and external sets. Conclusion Baseline NIHSS, D-dimer, RBG, BUN, and SBP before reperfusion were independent predictors for 3-month unfavorable outcome after reperfusion therapy in AIS patients. Both nomogram and ML models showed good discrimination and generalizability.


  • Open Access

    A Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies

    by Qianwen Wang, Yuhui Chen, Lingbing Meng, Jiawen Yin, Li Wang, Tao Gong

    Ischemic stroke is a life-threatening condition that also frequently results in long-term disability. Currently, intravenous thrombolysis with tissue plasminogen activator and mechanical thrombectomy is the most popular treatment. However, the narrow time window and related complications limit the treatment benefits. Exosomes have recently emerged as ideal therapeutic candidates for ischemic stroke with the ability to pass through the blood_brain barrier and mediate intercellular communication, in addition, exosomes and their contents can be bioengineered to implement targeted delivery. In the last two decades, exosomes and exosomal noncoding RNAs have been found to be involved in the pathophysiological progression of ischemic stroke, including atherosclerosis, apoptosis, inflammation, oxidative stress, and neurovascular remodeling. In this review, we describe the latest progress regarding the role of exosomal long noncoding RNAs and circular RNAs in the occurrence, progression, and recovery of ischemic stroke. Exploration of exosomal noncoding RNAs and their correlated effects in ischemic stroke may facilitate accurate diagnosis, and they may serve as new therapeutic targets for the disease.


  • Three‐dimensional ultrasound imaging: An effective method to detect the effect of moderate intensity statin treatment in slowing carotid plaque progression

    by Yuhui Chen, Haiying Xing, Jiexi Wen, Qing Peng, Ran Liu, Wei Sun, Haiqiang Jin, Ke Xu, Yining Huang

    Purpose We aimed to evaluate the feasibility of three‐dimensional ultrasound imaging (3DUS) in assessing the therapeutic effect of moderate‐intensity statin therapy on carotid atherosclerotic plaques. Methods Patients with carotid plaques were recruited to the study from January 2016 to September 2018, and were divided into two groups based on whether or not they were taking statins. All participants underwent 3DUS of their carotid plaques at baseline, then 3 months and 2 years after initial examination. The changes of the carotid plaques were compared between the two groups. Results Were included 97 patients (57 males and 40 females), 65.26 ± 9.53 year‐old with 67 into the statin group and 30 in the control group. The baseline levels of total cholesterol (TC) and low‐density lipoprotein cholesterol (LDL‐C) were lower in the statin group than in the control group (3.79 ± 0.78 mmol/L vs 4.50 ± 1.12 mmol/L; 2.01 ± 0.62 mmol/L vs 2.58 ± 0.91 mmol/L, P < .05). There was no significant difference in the change of total plaque volume (TPV) detected by 3D‐US between the statin (median [interquartile range]: 0 [−30‐20] mm3) and the control group (0 [−22.5‐25] mm3) at 3 months. Over 2 years, the TPV increased faster in the control group (+70 [25‐150] mm3), than in the statin group (15 [−57.5‐90) mm3, P < .05). Conclusions 3DUS can be an effective tool to observe the development of carotid plaques and the effect of statin treatment.